LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

Search

PerkinElmer Inc

Închisă

SectorSănătate

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Venit

-53M

42M

Vânzări

-65M

665M

P/E

Medie Sector

36.913

53.54

EPS

1.01

Randament dividend

0.31

Marjă de profit

6.268

Angajați

11,000

EBITDA

-50M

173M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+30.59% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.31%

2.44%

Următoarele câștiguri

28 iul. 2025

Data viitoare de dividende

8 aug. 2025

Următoarea dată ex-dividende

18 iul. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-3.5B

11B

Deschiderea anterioară

0

Închiderea anterioară

0

Sentimentul știrilor

By Acuity

21%

79%

42 / 381 Clasament în Healthcare

PerkinElmer Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 mai 2025, 10:30 UTC

Top știri

Pension Funds Won't Save the Bond Market -- Heard on the Street -- WSJ

31 mai 2025, 06:30 UTC

Câștiguri

5 Things We've Learned From Retail Earnings -- Barrons.com

31 mai 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30 mai 2025, 23:51 UTC

Achiziții, Fuziuni, Preluări

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 mai 2025, 21:30 UTC

Top știri

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 mai 2025, 21:15 UTC

Top știri

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 mai 2025, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

30 mai 2025, 20:44 UTC

Achiziții, Fuziuni, Preluări

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 mai 2025, 20:24 UTC

Top știri

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 mai 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30 mai 2025, 19:44 UTC

Market Talk

Gold Breaks 4-Month Winning Streak -- Market Talk

30 mai 2025, 19:38 UTC

Market Talk

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 mai 2025, 19:29 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 mai 2025, 19:14 UTC

Market Talk

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 mai 2025, 19:05 UTC

Market Talk

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 mai 2025, 18:51 UTC

Market Talk

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 mai 2025, 18:37 UTC

Market Talk
Câștiguri

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 mai 2025, 18:04 UTC

Top știri

S&P 500 Falls After More Trump-China Friction -- WSJ

30 mai 2025, 17:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mai 2025, 17:47 UTC

Market Talk

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 mai 2025, 17:40 UTC

Achiziții, Fuziuni, Preluări

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 mai 2025, 17:38 UTC

Market Talk

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 mai 2025, 17:31 UTC

Market Talk

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 mai 2025, 17:14 UTC

Top știri

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30 mai 2025, 16:31 UTC

Câștiguri

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30 mai 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

30 mai 2025, 16:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

30 mai 2025, 16:16 UTC

Top știri

S&P 500 Falls After Trump Hits Out at China -- WSJ

30 mai 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30 mai 2025, 16:14 UTC

Top știri

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

Comparație

Modificare preț

PerkinElmer Inc Așteptări

Obiectiv de preț

By TipRanks

30.59% sus

Prognoză pe 12 luni

Medie 118.08 USD  30.59%

Maxim 135 USD

Minim 100 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPerkinElmer Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

14 ratings

9

Cumpărare

5

Păstrare

0

Vânzare

Sentiment

By Acuity

42 / 381 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.